<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01230164</url>
  </required_header>
  <id_info>
    <org_study_id>09-03-016</org_study_id>
    <nct_id>NCT01230164</nct_id>
  </id_info>
  <brief_title>Comparison of Four Different Aberrometers for Evaluation of Higher Order Visual Aberrations</brief_title>
  <official_title>Comparison of Four Different Aberrometers for Evaluation of Higher Order Visual Aberrations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts Eye and Ear Infirmary</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts Eye and Ear Infirmary</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An aberrometer measures visual aberrations by mapping how light rays travel through the eye&#xD;
      and by providing maps using colored gradients to represent the magnitude of refractive errors&#xD;
      of the eye.&#xD;
&#xD;
      The purpose of this study is to compare 4 different aberrometers -Wavescan (Visx Technology),&#xD;
      Zywave (Bausch &amp; Lomb), Ladarwave aberrometer (Alcon Inc.) and Allegro Analyzer (Alcon Inc).&#xD;
      In particular, the investigators propose to focus on the ability of these devices to display&#xD;
      the higher order visual aberrations and to compare the quality of outputs from these 4&#xD;
      devices in normal healthy subjects.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">21</enrollment>
  <condition>Normal Individuals With Visual Aberrations</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Normal subjects over the age of 18 with visual abberations.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  male or female, at least 18 years of age&#xD;
&#xD;
          -  no ocular abnormality other than refractive error&#xD;
&#xD;
          -  patient in generally good &amp; stable overall health&#xD;
&#xD;
          -  has not worn contact lenses (hard or gas permeable lenses for at least 3 weeks and&#xD;
             soft lenses for at least 3 days) prior to the study exam&#xD;
&#xD;
          -  corneal topography must be normal, as judged by the investigator&#xD;
&#xD;
          -  topical anesthesia and mydriatics must be tolerated&#xD;
&#xD;
          -  patient must be able to fixate steadily&#xD;
&#xD;
          -  ability to understand and provide informed consent to participate in this study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of ocular surgery&#xD;
&#xD;
          -  history of ocular trauma, infection, disease, or abnormality other than refractive&#xD;
             error&#xD;
&#xD;
          -  myopia or hyperopia &gt; 7.0 D, astigmatism &gt;3.0 D&#xD;
&#xD;
          -  uncorrectable visual acuity below 20/20&#xD;
&#xD;
          -  abnormal corneal topography pattern including, but not limited to keratoconus, forme&#xD;
             fruste keratoconus, or corneal warpage&#xD;
&#xD;
          -  pupil sizes below 6.0 mm under mydriasis&#xD;
&#xD;
          -  iris problems including, but not limited to, coloboma and previous iris surgery&#xD;
&#xD;
          -  ocular media problems, corneal, lens and/or vitreous opacities including, but not&#xD;
             limited to cataract&#xD;
&#xD;
          -  ocular movement abnormalities including, but not limited to, strabismus or nystagmus&#xD;
&#xD;
          -  phenol red thread test (Zone Quick-Menicon Ltd) less than 9 mm/15 seconds&#xD;
&#xD;
          -  pregnancy and lactation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roberto Pineda, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts Eye and Ear Infirmary</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts Eye and Ear Infirmary</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <study_first_submitted>October 27, 2010</study_first_submitted>
  <study_first_submitted_qc>October 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2010</study_first_posted>
  <last_update_submitted>December 19, 2011</last_update_submitted>
  <last_update_submitted_qc>December 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 21, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

